Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Predictive Biosciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
Predictive Biosciences

Predictive Biosciences

Pre-Seed

Predictive Biosciences develops molecular tests and technologies for cancer diagnosis and monitoring in the US.

HQ
Lexington, KY, US
Founded
2006
Overview
Compare
Fundraising
Employees

Predictive Biosciences develops molecular tests and technologies for cancer diagnosis and monitoring in the US. The company offers biomarkers and proteomics-based technologies to detect urinary biomarkers associated with physiological changes, aiming to improve early detection and patient outcomes.

Key achievements include the development of advanced diagnostic tools that enhance cancer detection accuracy. Predictive Biosciences has significantly impacted the healthcare industry by providing reliable and non-invasive testing solutions, serving a broad customer base across the United States.

Predictive Biosciences - Similar Companies

Pbs-Bio logo

Pbs-Bio

Predictive Health Diagnostics Company logo

Predictive Health Diagnostics Company

Castle Biosciences logo

Castle Biosciences

Previse logo

Previse

previsedx.com

Matrix-Bio logo

Matrix-Bio

Biodesix logo

Biodesix

biodesix.com

Episteme Prognostics logo

Episteme Prognostics

epistemedx.com

Urology Diagnostics logo

Urology Diagnostics

PrognomiQ logo

PrognomiQ

prognomiq.com

EcoGenome logo

EcoGenome

ecogenomellc.com

Alamar Biosciences logo

Alamar Biosciences

alamarbio.com

Salish Bioscience logo

Salish Bioscience

Protean Biodiagnostics logo

Protean Biodiagnostics

proteanbiodx.com

PrognosDx Health logo

PrognosDx Health

Exact Sciences logo

Exact Sciences

exactsciences.com

Predictive Biosciences - Quick Facts

Who are Predictive Biosciences' competitors?

Companies similar to Predictive Biosciences include Pbs-Bio, Predictive Health Diagnostics Company, Castle Biosciences and Previse.

When was Predictive Biosciences founded?

Predictive Biosciences was founded in 2006.

Where is Predictive Biosciences' headquarters located?

Predictive Biosciences' headquarters is located in Lexington, KY, US.

When was Predictive Biosciences' last funding round?

Predictive Biosciences' most recent funding round was for $1.3M (USD) in January 2013.

How much has Predictive Biosciences raised to-date?

As of Jan 15, 2013, Predictive Biosciences has raised a total of $68.1M (USD).

How many employees does Predictive Biosciences have?

Predictive Biosciences has 75 employees as of Feb 4, 2024.

Predictive Biosciences - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Cancer Tests
Tags
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified